Zydus Lifesciences announces acquisition of 50% stake in Sterling Biotech's API business
09/17/24, 10:30 AM
Location
ahmedabadmumbaiIndustry
health care
biotechnology
manufacturing
Zydus Lifesciences has announced a crucial acquisition deal involving the acquisition of 50% stake in Sterling Biotech Ltd's Active Pharmaceutical Ingredients (API) Business. This strategic move aims to expand Zydus's portfolio and leverage SBL's fermentation-based products expertise and manufacturing facility in proximity to Zydus's existing facility.
Company Info
Location
Ahmedabad, Gujarat, India
Company info
After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd. Zydus has always been a purpose driven company. It has been our legacy of keeping patients and caregivers at the heart of everything we do. Backed by innovation, we have been exploring novel approaches in healthcare. As we continue to make a meaningful difference in the lives of patients, we hope to empower them and help them lead healthier and more fulfilled lives.